It’s a very different world now in cancer,” said longtime patient advocate Ginny Mason. “Now you need to understand the ...

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

Thomas Legacy Society members feel deeply that cancer and infectious disease must be stopped. They are devoted to inspiring our world-renowned scientists and powering the groundbreaking research that ...

Pain Clinic Services Cancer pain care needs to be carefully coordinated. It requires careful follow-up of issues and medications that can complicate a patient’s overall care. Cancer pain changes ...

Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community Grants Program. These grants, administered by the Office of Community ...

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

Innovators Network (IN) is a community of next-generation doers committed to funding cutting-edge research to end cancer and related diseases in their lifetime.

The Pacific Northwest (PNW) Prostate Cancer SPORE aims to focus on finding molecular and other factors associated with the risk of prostate cancer recurrence and progression as well as its response – ...